Lumos Diagnostics Holdings Limited
ASX:LDX.AX
0.031 (AUD) • At close February 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 11.131 | 10.535 | 11.63 | 18.854 | 5.794 | 4.481 | 1.92 |
| Cost of Revenue
| 4.033 | 4.563 | 7.174 | 10.253 | 3.282 | 2.444 | 1.08 |
| Gross Profit
| 7.098 | 5.972 | 4.456 | 8.601 | 2.512 | 2.037 | 0.839 |
| Gross Profit Ratio
| 0.638 | 0.567 | 0.383 | 0.456 | 0.434 | 0.455 | 0.437 |
| Reseach & Development Expenses
| 0.069 | 0.421 | 1.329 | 1.239 | 2.066 | 2.696 | 0.277 |
| General & Administrative Expenses
| 10.448 | 10.089 | 16.861 | 9.768 | 9.5 | 2.449 | 1.404 |
| Selling & Marketing Expenses
| 0.289 | 0.135 | 2.27 | 1.034 | 1.817 | 1.959 | 0.6 |
| SG&A
| 10.737 | 10.224 | 19.131 | 18.364 | 11.317 | 4.408 | 2.004 |
| Other Expenses
| -3.708 | 1.995 | 0.017 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 7.098 | 15.499 | 25.529 | 19.412 | 11.344 | 7.139 | 2.106 |
| Operating Income
| -5.008 | -10.236 | -21.494 | -11.002 | -10.72 | -2.888 | -1.287 |
| Operating Income Ratio
| -0.45 | -0.972 | -1.848 | -0.584 | -1.85 | -0.644 | -0.67 |
| Total Other Income Expenses Net
| -3.584 | -2.41 | -21.838 | -4.028 | 1.531 | -2.319 | 0.02 |
| Income Before Tax
| -8.592 | -8.971 | -45.724 | -15.03 | -9.34 | -5.207 | -1.267 |
| Income Before Tax Ratio
| -0.772 | -0.852 | -3.932 | -0.797 | -1.612 | -1.162 | -0.66 |
| Income Tax Expense
| 0 | 2.366 | 0.189 | 0 | 0.059 | 0.611 | 0 |
| Net Income
| -8.592 | -8.971 | -45.724 | -15.03 | -9.28 | -4.596 | -1.267 |
| Net Income Ratio
| -0.772 | -0.852 | -3.932 | -0.797 | -1.602 | -1.026 | -0.66 |
| EPS
| -0.019 | -0.038 | -0.3 | 0 | -0.42 | -0.27 | 0 |
| EPS Diluted
| -0.019 | -0.038 | -0.3 | 0 | -0.42 | -0.27 | 0 |
| EBITDA
| -5.436 | -4.929 | -18.671 | -10.691 | -10.414 | -2.759 | -1.229 |
| EBITDA Ratio
| -0.488 | -0.406 | -1.605 | -0.567 | -1.797 | -0.616 | -0.64 |